Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 95.10% vs 140.27% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 47.06% vs 54.55% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is 57.14% vs 21.15% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 137.26% vs 47.26% in Mar 2024
Compare Balance Sheet Results of Aptus Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
5.00
15.74
-10.74
-68.23%
Share Warrants & Outstandings
Total Reserve
1.97
35.76
-33.79
-94.49%
Shareholder's Funds
6.97
51.50
-44.53
-86.47%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
2.62
1.99
0.63
31.66%
Secured Loans
1.51
0.00
1.51
0.00%
Unsecured Loans
1.11
1.99
-0.88
-44.22%
Deferred Tax Assets / Liabilities
-0.07
-0.71
0.64
90.14%
Other Long Term Liabilities
0.25
0.00
0.25
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
2.80
1.28
1.52
118.75%
Current Liabilities
Trade Payables
1.31
4.18
-2.87
-68.66%
Other Current Liabilities
3.04
2.14
0.90
42.06%
Short Term Borrowings
7.74
3.93
3.81
96.95%
Short Term Provisions
0.00
0.00
0.00
0.00%
Total Current Liabilities
12.08
10.25
1.83
17.85%
Total Liabilities
21.85
63.03
-41.18
-65.33%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
1.86
5.92
-4.06
-68.58%
Less: Accumulated Depreciation
0.87
0.00
0.87
0.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.99
5.92
-4.93
-83.28%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.28
-0.28
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.82
-0.82
-100.00%
Long Term Loans & Advances
0.00
1.35
-1.35
-100.00%
Other Non Current Assets
1.12
0.00
1.12
0.00%
Total Non-Current Assets
2.11
8.37
-6.26
-74.79%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
7.06
4.56
2.50
54.82%
Sundry Debtors
5.64
5.98
-0.34
-5.69%
Cash and Bank
5.21
30.70
-25.49
-83.03%
Other Current Assets
0.00
6.94
-6.94
-100.00%
Short Term Loans and Advances
1.82
6.48
-4.66
-71.91%
Total Current Assets
19.74
54.66
-34.92
-63.89%
Net Current Assets (Including Current Investments)
7.65
44.41
-36.76
-82.77%
Total Current Assets Excluding Current Investments
19.74
54.66
-34.92
-63.89%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
21.85
63.03
-41.18
-65.33%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
10.36
5.92
4.44
75.00%
Book Value per share (adjusted)
13.93
32.71
-18.78
-57.41%
Annual - Borrowings
Borrowings 10.36 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 95.10% vs 140.27% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.25 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 47.06% vs 54.55% in Mar 2024
Annual - Fixed Assets
Fixed Assets 0.99 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 57.14% vs 21.15% in Mar 2024
Annual - Investments
Investments 0.00 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 19.74 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 137.26% vs 47.26% in Mar 2024






